Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study

2015312 citationsJournal Article

Authors

M. Cavallin · University of Padua

Salvatore Piano · University of Padua

Antonietta Romano · University of Padua

Silvano Fasolato · University of Padua

Anna Chiara Frigo · University of Padua

Gianpiero Benetti · ASST Melegnano e della Martesana

Elisabetta Gola ·

Abstract

Terlipressin given by continuous intravenous infusion is better tolerated than intravenous boluses in the treatment of type 1 HRS. Moreover, it is effective at doses lower than those required for intravenous bolus administration.

Topics & Keywords

Liver Disease and Transplantation Liver Disease Diagnosis and Treatment Organ Transplantation Techniques and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 63, Issue 3, pp. 983-992

DOI: 10.1002/hep.28396

Field-Weighted Citation Impact: 10.37